Delays bringing medical treatment to market can cost pharmaceutical companies millions of dollars a day in lost revenue. And as treatments take 10 to 12 years to be greenlit, companies need to start production immediately after approval. Thus, engineers must design plants before product, recipe and workflow finalization. This introduces significant uncertainty within a project that demands success on first use.
In this episode, experts in the pharmaceutical and life science industry discuss how Roche uses a comprehensive digital twin to overcome the uncertainties related to the design of greenfield, pharmaceutical production facilities.
In this podcast you will learn:
(01:40) How to adapt to the big changes in the pharmaceutical space
(03:50) How to overcome the challenges of building greenfield plants for life sciences
(06:05) How Roche’s new project addresses plant development uncertainty
(13:58) When comprehensive digital twins transition from models to decision tools
About the voices:
Jan Wokittel, Director of Smart Manufacturing at Roche
Jan is responsible for the digitization technologies used in greenfield pharmaceutical and medical device production facilities. For over seven years, he has helped Roche plan and implement large scale capital expenditure projects.
Andy Whytock, Head of Market Strategy and Thought Leadership of Life Sciences at Siemens
Andy is responsible for driving digital transformation initiatives and thought leadership activities in the pharmaceutical and life sciences sector. He specializes in helping life sciences manufacturers embrace digital transformation, adopt cutting-edge technologies and evolve into fully connected, data-driven and sustainable enterprises.
Conor Peick, Marketing Professional for the Thought Leadership team at Siemens Digital Industries Software
Conor is responsible for creating forward-looking content for Siemens Digital Industries Software.